Search research articles
Contact Us
Filters
Showing results (161-170 of 175) with videos related to
Page
of 18
Sort By:
Vaccine
|
November 9, 2020
Assignment of opsonic values to pneumococcal reference serum 007sp and a second pneumococcal OPA calibration serum panel (Ewha QC sera panel B) for 11 serotypes
Robert L Burton, Han Wool Kim, Soyoung Lee, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 23, 2026
Blood Pressure Trajectories in Young Adulthood and Midlife Steatotic Liver Disease
Yun Chen, Longgang Zhao, Yinan Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2022
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
Kyung-Don Kang, Joshua D Bernstock, Stacie K Totsch, et al.
Experimental Dermatology
|
December 4, 2018
Ultraviolet radiation, both UVA and UVB, influences the composition of the skin microbiome
Erin M Burns, Hana Ahmed, Prescilia N Isedeh, et al.
Journal of the American College of Cardiology
|
March 22, 2023
Association of Incident Cardiovascular Disease With Time Course and Cumulative Exposure to Multiple Risk Factors
Michael J Domanski, Colin O Wu, Xin Tian, et al.
JACC. Advances
|
May 24, 2025
Association of Race With Risk of Incident Cardiovascular Disease, Coronary Heart Disease, Heart Failure, and Stroke
Michael J Domanski, Colin O Wu, Xin Tian, et al.
Cancer Discovery
|
September 4, 2014
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer
Eun-Hee Shim, Carolina B Livi, Dinesh Rakheja, et al.
NPJ Breast Cancer
|
October 23, 2018
Molecular determinants of post-mastectomy breast cancer recurrence
Kimberly S Keene, Tari King, E Shelley Hwang, et al.
The Journal of Clinical Investigation
|
May 14, 2024
l-2-Hydroxyglutarate remodeling of the epigenome and epitranscriptome creates a metabolic vulnerability in kidney cancer models
Anirban Kundu, Garrett J Brinkley, Hyeyoung Nam, et al.
Molecular Cancer
|
March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma
Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 175) with videos related to
Sort By:
Page
of 18
Vaccine
|
November 9, 2020
Assignment of opsonic values to pneumococcal reference serum 007sp and a second pneumococcal OPA calibration serum panel (Ewha QC sera panel B) for 11 serotypes
Robert L Burton, Han Wool Kim, Soyoung Lee, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 23, 2026
Blood Pressure Trajectories in Young Adulthood and Midlife Steatotic Liver Disease
Yun Chen, Longgang Zhao, Yinan Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2022
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
Kyung-Don Kang, Joshua D Bernstock, Stacie K Totsch, et al.
Experimental Dermatology
|
December 4, 2018
Ultraviolet radiation, both UVA and UVB, influences the composition of the skin microbiome
Erin M Burns, Hana Ahmed, Prescilia N Isedeh, et al.
Journal of the American College of Cardiology
|
March 22, 2023
Association of Incident Cardiovascular Disease With Time Course and Cumulative Exposure to Multiple Risk Factors
Michael J Domanski, Colin O Wu, Xin Tian, et al.
JACC. Advances
|
May 24, 2025
Association of Race With Risk of Incident Cardiovascular Disease, Coronary Heart Disease, Heart Failure, and Stroke
Michael J Domanski, Colin O Wu, Xin Tian, et al.
Cancer Discovery
|
September 4, 2014
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer
Eun-Hee Shim, Carolina B Livi, Dinesh Rakheja, et al.
NPJ Breast Cancer
|
October 23, 2018
Molecular determinants of post-mastectomy breast cancer recurrence
Kimberly S Keene, Tari King, E Shelley Hwang, et al.
The Journal of Clinical Investigation
|
May 14, 2024
l-2-Hydroxyglutarate remodeling of the epigenome and epitranscriptome creates a metabolic vulnerability in kidney cancer models
Anirban Kundu, Garrett J Brinkley, Hyeyoung Nam, et al.
Molecular Cancer
|
March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma
Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Page
of 18